As the biopharma industry continues to show expansion, the incremental effect on bioprocessing is apparent, and is ushering in new therapies, new technologies, and new process innovations. And this against the backdrop of a continued need for process efficiency improvement and lower costs. Further, Bioprocess 4.0 is rapidly evolving, and posing new opportunities.
The 5th Bioprocess & Technology will address regulatory, investment, process development and technical innovation to keep participants at the forefront of industry.
Still have a question?